|
|
Volumn 18, Issue 12, 2001, Pages 1313-1321
|
|
Repinotan (BAY × 3702): A 5HT1A agonist in traumatically brain injured patients
a b c
c
Bayer Pharma
(France)
|
|
Author keywords
5HT1AIntracranial pressure; Preliminary GOS scores; Repinotan; Safety; Severe traumatic brain injury
|
|
Indexed keywords
PLACEBO;
REPINOTAN;
SEROTONIN 1A AGONIST;
BENZOPYRAN DERIVATIVE;
SEROTONIN 1 RECEPTOR;
SEROTONIN AGONIST;
SEROTONIN RECEPTOR;
THIAZOLE DERIVATIVE;
ADULT;
AGED;
ARTICLE;
BINDING AFFINITY;
BRAIN INJURY;
CLINICAL TRIAL;
CONTINUOUS INFUSION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG BLOOD LEVEL;
DRUG INDICATION;
DRUG INDUCED DISEASE;
DRUG MECHANISM;
DRUG RECEPTOR BINDING;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
FOLLOW UP;
GLASGOW COMA SCALE;
HEMODYNAMIC MONITORING;
HUMAN;
INAPPROPRIATE VASOPRESSIN SECRETION;
INTRACRANIAL PRESSURE;
MAJOR CLINICAL STUDY;
MALE;
NEUROPROTECTION;
RANDOMIZED CONTROLLED TRIAL;
SEROTONINERGIC SYSTEM;
TREATMENT OUTCOME;
ADOLESCENT;
BLOOD PRESSURE;
COMPARATIVE STUDY;
DRUG EFFECT;
MIDDLE AGED;
MULTICENTER STUDY;
PATHOLOGY;
PATIENT;
PHYSIOLOGY;
STATISTICS;
ADOLESCENT;
ADULT;
AGED;
BENZOPYRANS;
BLOOD PRESSURE;
BRAIN INJURIES;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PATIENTS;
RECEPTORS, SEROTONIN;
RECEPTORS, SEROTONIN, 5-HT1;
SEROTONIN AGONISTS;
THIAZOLES;
TREATMENT OUTCOME;
|
|
EID: 85047697910
PISSN: 08977151
EISSN: None
Source Type: Journal
DOI: 10.1089/08977150152725614 Document Type: Article |
|
Times cited : (28)
|
|
References (23)
|
